News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ChinaBio Today Release: Barclays Remains Negative on Most China Pharma Stocks Near-Term



4/5/2012 9:35:51 AM

April 4, 2012 -- Based in part on a ChinaBio® survey, Barclays has reiterated its downbeat outlook for China healthcare companies for the rest of 2012. The ChinaBio study showed that industry participants remain pessimistic about the near-term future. Jason Mann, MD, PhD, the Barclays analyst for the sector, used the survey results to underline the difference between insiders, who see more difficulties ahead, and outsiders, who remain overly optimistic in his opinion. More details....

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES